close
close

Victorian researchers develop future treatments for pandemics | News & Articles

Victorian researchers develop future treatments for pandemics | News & Articles
Victorian researchers develop future treatments for pandemics | News & Articles

Thanks to support from the Victorian Government, researchers are accelerating the development of new medical technologies and life-saving virus treatments.

Monash University’s expanded Medicines Manufacturing Innovation Centre (MMIC) in Clayton is one of 10 research projects to receive a share of $5 million in funding through the latest round of Cumming Global Centre for Pandemic Therapeutics Foundation Grants.

The grants will enable researchers around the world to discover new technologies and accelerate the development of treatments for viruses and infectious diseases that could cause pandemics in the future.

Victoria leads the way by securing more than half of the Cumming Global Centre’s total funding for this round, with grants also awarded to the Walter and Eliza Hall Institute in Parkville and the CSIRO Australian Centre for Disease Preparedness in Geelong.

Thanks to a grant from the Cumming Global Centre, Monash University’s MMIC is developing a novel therapeutic agent to treat respiratory viruses and prevent lung infections.

Monash recently opened its expanded MMIC facility in Clayton, one of three core areas in the Monash Technology Precinct that benefited from a $16.1 million investment through the Victorian Higher Education State Investment Fund. It builds on the work of the Parkville centre to enhance R&D and increase local drug manufacturing capacity.

The Victorian Government has established world-leading medical research facilities, including the Australian Institute for Infectious Disease and the Cumming Global Centre, and opened Moderna’s first mRNA vaccine manufacturing facility outside North America in Melbourne.

View the full list of funded projects at: cgcpt.edu.au